NCT00897754View on ClinicalTrials.gov

Gene Expression in Patients With Advanced or Metastatic Colorectal Cancer Receiving Bevacizumab

CompletedOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

July 24, 2007

Primary Completion Date

February 1, 2009

Study Completion Date

February 1, 2009

Conditions
Colorectal Cancer
Interventions
GENETIC

gene expression analysis

GENETIC

protein expression analysis

GENETIC

reverse transcriptase-polymerase chain reaction

OTHER

immunoenzyme technique

OTHER

immunohistochemistry staining method

OTHER

immunologic technique

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

ECOG-ACRIN Cancer Research Group

NETWORK

NCT00897754 - Gene Expression in Patients With Advanced or Metastatic Colorectal Cancer Receiving Bevacizumab | Biotech Hunter | Biotech Hunter